The purpose of the VICC Human Tissue Acquisition and Pathology Shared Resource (HTAP) is to provide support for Cancer Center investigators engaged in translational and basic science research efforts. It provides researchers with access to a wide variety of human specimens and tissues. The objectives of HTAP are to collect, process, bank, and distribute remnant human tissues (both normal and neoplastic) from routine surgical resections and autopsies for use by peer-reviewed funded investigators of the VICC in basic, clinical, and translational research studies; provide the highest quality of well-characterized fresh, frozen, and fixed tissues suitable for a wide range of molecular, biochemical, and tissue analyses; assist with collection and banking of biopsy material for specific cancer-related clinical trials and other projects; provide, as feasible, human tissues to other peer-reviewed funded Vanderbilt University investigators who are not members of the VICC, and to newly-established investigators who have yet to receive funding; and to perform quality control to ensure that the relevant tissue is supplied to the researcher, and that tissues are suitable for the planned research (e.g., not necrotic or involved by unsuspected disease processes.) New services offered by HTAP include laser capture microscopy, tissue array block construction, and access to the BLISS automated software/imaging system. In addition, tissue collection efforts have been extensively refined and new preservation methods offered. Dr. Kay Washington is the Director of the Human Tissue Acquisition and Pathology Shared Resource and is engaged in a number of collaborative projects with VICC investigators. She is assisted by a staff with decades of experience in offering these services, and partners with the Bioinformatics Shared Resource, under the direction of Dr. Mary Edgerton, to develop easily-customized tools for specimen tracking and linkage of genomic, proteomic and biologic data to tissue specimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-12
Application #
7495654
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
12
Fiscal Year
2007
Total Cost
$374,649
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Payton, Rebecca R; Rispoli, Louisa A; Nagle, Kimberly A et al. (2018) Mitochondrial-related consequences of heat stress exposure during bovine oocyte maturation persist in early embryo development. J Reprod Dev 64:243-251
Kovtun, Oleg; Tomlinson, Ian D; Bailey, Danielle M et al. (2018) Single Quantum Dot Tracking Illuminates Neuroscience at the Nanoscale. Chem Phys Lett 706:741-752
Goff, Laura W; Azad, Nilofer S; Stein, Stacey et al. (2018) Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer. Invest New Drugs :
Weigl, Korbinian; Thomsen, Hauke; Balavarca, Yesilda et al. (2018) Genetic Risk Score Is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer Screening Population. Gastroenterology 155:88-98.e10
Johnson, Douglas B; Dahlman, Kimberly B (2018) Class Matters: Sensitivity of BRAF-Mutant Melanoma to MAPK Inhibition. Clin Cancer Res 24:6107-6109
Schlegel, Cameron; Lapierre, Lynne A; Weis, Victoria G et al. (2018) Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase. Traffic 19:879-892
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58

Showing the most recent 10 out of 2462 publications